Endoscopic treatment for common bile duct safe for elderly adults
Endoscopic treatment for common bile duct (CBD) is effective and safe in elderly adults aged 85 years and above, a recent study has found.
The study included 335 patients who received endoscopic treatments for CBD stones; 185 patients were aged <85 years (group A; mean age 71±12.8 years; 63.2 percent male), while 50 were ≥85 years old (group B; mean age 88±3.0 years; 40.0 percent male).
Both groups had statistically comparable overall rates of complications during the procedure (8.6 vs 14.0 percent). The rates of blood pressure reductions (1.6 vs 0 percent) and peripheral oxygen saturation reductions (2.7 vs 2.0 percent) during the procedure were also similar between groups.
Notably, overall complication rates after the procedure did not significantly differ between groups A and B (20.0 vs 18.0 percent). The incidence rates of pancreatitis (16.8 vs 12.0 percent), cholangitis (3.2 vs 2.0 percent), and bleeding (1.1 vs 4.0 percent) were also statistically similar between the two patient groups.
In terms of the clinical course after endoscopy, only the rates of cholecystectomy after the procedure differed significantly between the two groups, with patients in group A reporting statistically higher rates than those in group B (58.4 vs 24.0 percent; p<0.001).
Other clinical parameters, such as length of hospital stay (15.2 vs 17.6 days), mortality rate (1.1 vs 0 percent), recurrence of CBD stones during follow-up (13.0 vs 20.0 percent), and observational period duration (4.4 vs 3.4 years), remained statistically comparable between the groups.